Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Síndrome 5q")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 45

  • Page / 2
Export

Selection :

  • and

Utilisation du lénalidomide dans les syndromes myélodysplasiques del(5q)ADES, L.Correspondances en onco-hématologie. 2014, Vol 9, Num 2, pp 76-80, issn 1954-4820, 5 p.Article

Advances in the 5q- syndromeBOULTWOOD, Jacqueline; PELLAGATTI, Andrea; MCKENZIE, Andrew N. J et al.Blood. 2010, Vol 116, Num 26, pp 5803-5811, issn 0006-4971, 9 p.Article

Erythropoïèse des syndromes myélodysplasiques: cas du syndrome 5qVINCENT, Laure.Hématologie (Montrouge). 2010, Vol 16, pp 17-20, issn 1264-7527, 4 p., SUP3Conference Paper

Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic SyndromesGIAGOUNIDIS, Aristoteles A. N.Seminars in hematology. 2012, Vol 49, Num 4, pp 312-322, issn 0037-1963, 11 p.Article

Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletionDEFINA, Marzia; RONDONI, Michela; GOZZETTI, Alessandro et al.British journal of haematology. 2010, Vol 148, Num 3, pp 483-484, issn 0007-1048, 2 p.Article

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndromeLOPEZ-VILLAR, O; GARCIA, J. L; HERNANDEZ-RIVAS, J. M et al.Leukemia. 2009, Vol 23, Num 4, pp 664-672, issn 0887-6924, 9 p.Article

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblastsYIP, B. H; PELLAGATTI, A; WAINSCOAT, J. S et al.Leukemia. 2012, Vol 26, Num 9, pp 2154-2158, issn 0887-6924, 5 p.Article

Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletionXIMERI, Maria; GALANOPOULOS, Athanasios; HATZIMICHAEL, Eleftheria et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 406-414, issn 0390-6078, 9 p.Article

Haploinsufficiency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal-and translation-related genesPELLAGATTI, Andrea; HELLSTRÖM-LINDBERG, Eva; WAINSCOAT, James S et al.British journal of haematology. 2008, Vol 142, Num 1, pp 57-64, issn 0007-1048, 8 p.Article

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomideGÖHRING, G; LANGE, K; SCHLEGELBERGER, B et al.Leukemia. 2012, Vol 26, Num 2, pp 356-358, issn 0887-6924, 3 p.Article

Identification of RPS14 as a 5q-syndrome gene by RNA interference screenEBERT, Benjamin L; PRETZ, Jennifer; GOLUB, Todd R et al.Nature (London). 2008, Vol 451, Num 7176, pp 335-339, issn 0028-0836, 5 p.Article

Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomideECLACHE, Virginie; DA ROCHA, Anna; LE ROUX, Génevieve et al.Haematologica (Roma). 2008, Vol 93, Num 2, pp 315-316, issn 0390-6078, 2 p.Article

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5qMALLO, M; CERVERA, J; BLUM, S et al.Leukemia. 2011, Vol 25, Num 1, pp 110-120, issn 0887-6924, 11 p.Article

Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell studyGARDERET, Laurent; KOBARI, Ladan; MAZURIER, Christelle et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 398-405, issn 0390-6078, 8 p.Article

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancerEBERT, B. L.Leukemia. 2009, Vol 23, Num 7, pp 1252-1256, issn 0887-6924, 5 p.Article

Traitement des syndromes myélodysplasiques : Perspectives des thérapeutiques de première ligne (partie II) = Treatment of myelodysplastic syndromesDREYFUS, F.Correspondances en onco-hématologie. 2009, Vol 4, Num 3, issn 1954-4820, 114-119 [5 p.]Article

Blood consult: treating del(5q) myelodysplastic syndromesMUKHERJEE, Sudipto; TIU, Ramon V; SEKERES, Mikkael A et al.Blood. 2012, Vol 119, Num 2, pp 342-344, issn 0006-4971, 3 p.Article

NPM1 gene deletions in myelodysplastic syndromes with 5q- and complex karyotypeAMMATUNA, Emanuele; PANETTA, Paola; AGIRRE, Xabier et al.Haematologica (Roma). 2011, Vol 96, Num 5, pp 784-785, issn 0390-6078, 2 p.Article

Different boundaries characterize isolated and non-isolated 5q deletions in myelodysplastic syndromes and acute myeloid leukemiasNOFRINI, Valeria; LA STARZA, Roberta; CRESCENZI, Barbara et al.Haematologica (Roma). 2012, Vol 97, Num 5, pp 792-794, issn 0390-6078, 3 p.Article

SPARC is dispensable for murine hematopoiesis, despite its suspected pathophysiological role in 5q-myelodysplastic syndromeSIVA, K; JAAKO, P; MIHARADA, K et al.Leukemia. 2012, Vol 26, Num 11, pp 2416-2419, issn 0887-6924, 4 p.Article

Molecular Dissection of the 5q Deletion in Myelodysplastic SyndromeEBERT, Benjamin L.Seminars in oncology. 2011, Vol 38, Num 5, pp 621-626, issn 0093-7754, 6 p.Article

Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survivalCZIBERE, Akos; BRUNS, Ingmar; JUNGE, Bärbel et al.Haematologica (Roma). 2009, Vol 94, Num 10, pp 1453-1455, issn 0390-6078, 3 p.Article

Van-den Berghe's 5q-syndrome in 2008MOHAMEDALI, Azim; MUFTI, Ghulam J.British journal of haematology. 2009, Vol 144, Num 2, pp 157-168, issn 0007-1048, 12 p.Article

TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease ProgressionJÄDERSTEN, Martin; SAFT, Leonie; HELLSTRÖM-LINDBERG, Eva et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 1971-1979, issn 0732-183X, 9 p.Article

Molecular pathogenesis in Diamond-Blackfan anemia : PIH: Recent advances in inherited bone marrow failure syndromesITO, Etsuro; KONNO, Yuki; TOKI, Tsutomu et al.International journal of hematology. 2010, Vol 92, Num 3, pp 413-418, issn 0925-5710, 6 p.Article

  • Page / 2